ResearcherUniversity of Tokyo HospitalNo recent work listed

Kazuhiro Kakimi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2631-3040; OpenAlex author ID A5013524621. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2017.12.083 ↗
Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer. Last author DOI 10.1016/j.jcyt.2017.01.002 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mayumi Hoshikawa · 2 shared papers, 2017–2018 · strength 0.15
- Paper Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pa… DOI 10.1016/j.jcyt.2017.01.002 ↗
- Paper NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. DOI 10.1016/j.bbrc.2017.12.083 ↗
Kiyoshi Hasegawa · 2 shared papers, 2017–2018 · strength 0.15
- Paper Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pa… DOI 10.1016/j.jcyt.2017.01.002 ↗
- Paper NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. DOI 10.1016/j.bbrc.2017.12.083 ↗
Taku Aoki · 2 shared papers, 2017–2018 · strength 0.15
- Paper Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pa… DOI 10.1016/j.jcyt.2017.01.002 ↗
- Paper NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. DOI 10.1016/j.bbrc.2017.12.083 ↗
Norihiro Kokudo · 2 shared papers, 2017–2018 · strength 0.15
- Paper Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pa… DOI 10.1016/j.jcyt.2017.01.002 ↗
- Paper NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer. DOI 10.1016/j.bbrc.2017.12.083 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.